Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-461-875"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-10-23"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20121023.45.2-461-875"2
lpv:hasSubsequent	lp_eu:2012-10-23-Speech-2-462-0002
lpv:speaker	lp:João Ferreira2
lpv:spokenAs	member; Delegation to the EU-Former Yugoslav Republic of Macedonia Joint Parliamentary Committee (2009-09-16--2013-02-03)3 unknown; Partido Comunista Português (2009-07-14--2014-06-30)3 substitute; Delegation for relations with the countries of the Andean Community (2009-09-16--2014-06-30)3 vice-chair; EUL/NGL (2012-02-07--2014-06-30)3 member; PECH (2012-01-19--2014-06-30)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; ENVI (2012-01-19--2014-06-30)3 substitute; BUDG (2012-01-19--2014-06-30)3
lpv:translated text	"In May 2012 Parliament refused to grant discharge for the financial year 2010 to the European Medicines Agency (EMA) due to clear irregularities in the recruitment process, given that there was one ‘revolving door’ case and conflicts of interest between management staff and experts. According to this second report, the Agency has made progress in resolving these issues, by improving ‘the scope and methodology of the systematic ex-ante and ex-post controls related to the screening of declaration of interest’. Consequently, we voted in favour of closing the EMA accounts."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph